Relationship between nonalcoholic fatty liver disease and bone mineral density in elderly Chinese

J Orthop Surg Res. 2023 Sep 13;18(1):679. doi: 10.1186/s13018-023-04168-8.

Abstract

Objective: As our society grows older, both bone loss and fatty liver have become important issues. However, the relationship between reduced bone mineral density and fatty liver remains controversial. The purpose of this study was to investigate the relationship between nonalcoholic fatty liver disease and less bone mineral density in the ankles of Chinese people over 65.

Methods: The research included 716 older adults over the age of 65 who underwent a comprehensive health screening. A logistic regression model was used to investigate the relationship between nonalcoholic fatty liver disease (NAFLD) and ankle bone mineral density.

Results: A logistic regression model was used to analyze the odds ratios of reduced bone mineral density between patients with fatty liver and controls. In the adjusted model, adjustments were made for age, sex, systolic blood pressure, diastolic blood pressure, overweight rate, history of hypertension, history of diabetes, history of smoking, history of alcohol consumption, fasting glucose, hemoglobin, urea, creatinine, triglycerides, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, waist circumference, total protein, albumin, and globulin. The adjusted OR (aOR) for reduced bone mineral density was 0.66 [95% confidence interval (CI) = 0.45-0.97, P = 0.034 < 0.05]. In subgroup analysis by age, sex, and BMI, women, age > 75 years, and BIM < 25 were statistically significant.

Conclusion: This study suggested that NAFLD is associated with a reduced risk of reduced heel bone mass. More research needs to be done to back up the results of this study and look into possible problems.

Keywords: Aging population; Bone mineral density; Cross-sectional study; Nonalcoholic fatty liver disease; Osteopenia.

MeSH terms

  • Aged
  • Bone Density
  • Bone Diseases, Metabolic*
  • Cholesterol, HDL
  • East Asian People
  • Female
  • Humans
  • Non-alcoholic Fatty Liver Disease* / epidemiology

Substances

  • Cholesterol, HDL